Clinical Trial

Xanthigen and Its Impact on Weight and Metabolic Health

Study acronym: XAN
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 7, 2026 (before its estimated July 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
Randomized, controlled, triple-blind clinical trial with three parallel arms based on the product consumed (low-dose experimental product, high-dose experimental product, and placebo product) and conducted at a single center to measure the efficacy of a product (Xanthigen®) on overweight or obesity during 16 weeks of consumption.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-06.
Trial Details
NCT Number NCT07519980
Lead Sponsor Universidad Católica San Antonio de Murcia
Conditions Obesity & Overweight
Enrollment 180 participants
Start Date 2026-02-02
Primary Completion 2026-07-20 (estimated)
Study Completion 2026-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-07